Market expansion CEFALY Technology has an established global orientation with a multi-year track record in drug-free migraine therapy and recent partnerships with payors and healthcare providers, signaling opportunities to expand into payer networks, clinical pathways, and broader US public and VA health systems.

Digital health Expansion of CeCe Migraine Management app and Headaches.com indicates appetite for connected care and patient engagement platforms, creating cross-sell opportunities for telehealth integrations, data-driven care plans, and digital adherence programs to boost device usage.

Strategic partnerships Ongoing collaborations with PayrHealth, Elexes, and Veterans Affairs demonstrate a favorable stance toward contract-based reimbursement and regulatory support, suggesting targeted outreach to payors, MSPs, and hospital systems to secure favorable coverage and procurement.

Clinical positioning Positioned as non-invasive neuromodulation targeting the trigeminal pathway, the company can pursue partnerships with neurology and headache clinics, pain management programs, and VA/VA-adjacent networks seeking safe, drug-free migraine options to broaden adoption.

Growth signals Revenue scale and small-to-mid company size imply agile sales cycles and room to upsell device bundles, service contracts, and integrated digital tools to existing customers, as well as channel partnerships with medical distributors and telemedicine platforms.